Evidence map›Paper›PMID 41051600›Full record

ReviewJournal of fluorescence2026

Quantum Dots: Catalysts for a New Era of Precision Medicine and Biomedical Innovation.

Ali Alsuraifi, Mohammed M Mouzan, Abdullah Algzaare, Zaid Aqeel, Umalbaneen I Al-Essa, Noor Alhuda R Mohammed, Abdullah Ayad

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Head and neck squamous cell carcinoma: current and emerging therapeutic strategies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ali AlsuraifiCollege of Dentistry, University of Basrah, Basrah, 61004, Iraq. ali.yassen@uobasrah.edu.iq.ORCID http://orcid.org/0000-0003-4809-6104
Mohammed M MouzanCollege of Dentistry, University of Basrah, Basrah, 61004, Iraq.ORCID http://orcid.org/0009-0001-4723-4942
Abdullah AlgzaareCollege of Dentistry, University of Basrah, Basrah, 61004, Iraq.ORCID http://orcid.org/0009-0009-0956-0307
Zaid AqeelCollege of Dentistry, University of Basrah, Basrah, 61004, Iraq.ORCID http://orcid.org/0009-0007-9446-885X
Umalbaneen I Al-EssaCollege of Dentistry, University of Basrah, Basrah, 61004, Iraq.ORCID http://orcid.org/0009-0009-9986-3861
Noor Alhuda R MohammedCollege of Dentistry, University of Basrah, Basrah, 61004, Iraq.ORCID http://orcid.org/0009-0009-5167-7517
Abdullah AyadCollege of Dentistry, University of Basrah, Basrah, 61004, Iraq. abdullah.ayad@bayangen.com.ORCID http://orcid.org/0009-0002-2799-6277

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantum dots have emerged as transformative nanomaterials whose extraordinary optical and electronic properties are revolutionizing precision medicine and biomedical innovation. This comprehensive review synthesizes multidisciplinary advances from cutting-edge eco-friendly and biogenic synthesis methods to sophisticated surface modification strategies such as ligand engineering, zwitterionic polymer coatings, and congeneric passivation, which together increase biocompatibility, reduce nonspecific binding, and prolong in vivo circulation. We explore the development of multifunctional hybrid nanocomposites, including QD-gold nanostars and QD/MoS₂ systems, which exhibit remarkable performance in multimodal imaging, fluorescence-guided surgery, and smart drug delivery applications. Furthermore, this review highlights the pivotal role of QDs in photothermal and photodynamic therapies, where their capacity to convert light into localized therapeutic effects paves the way for innovative cancer and dental treatments. Emphasis is placed on the integration of QDs as traceable carriers for targeted drug delivery, enabling real-time monitoring and controlled release via pH-sensitive and enzyme-responsive systems. Despite persistent challenges such as scalability, reproducibility, and concerns over heavy metal toxicity, ongoing interdisciplinary research is steadily overcoming these hurdles. By merging innovative synthesis, precise surface engineering, and strategic hybridization, QDs are positioned as critical components of next-generation diagnostic and therapeutic platforms that promise personalized, minimally invasive, and highly effective treatment modalities.

Indexed as

Precision MedicineQuantum DotsAnimalsCatalysisHumansBioimagingGreen synthesisNanomedicinePhototherapyQuantum dotsTargeted drug delivery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.